| CORRESPONDING AUTHOR |
E-MAIL |
TITLE |
| Abel, Frida |
 |
Imbalance of transcripts encoding mitochondrial pro- and anti-apoptotic members in unfavorable neuroblastoma |
| Alaminos, Miguel |
|
EMP3, A Putative Tumor Suppressor Gene Mapping At 19q13.3, Is Epigenetically Silenced In Neuroblastoma By Promoter Hypermethylation and May Have Prognostic Value |
| Alaminos, Miguel |
|
A clustering of gene hypermethylation distinguishes high and low-risk neuroblastoma patients |
| Amato, Ilaria |
|
Biological modifiers of RANKL activity prevents osteoclastogenesis induced by neuroblastoma cells |
| Ambros, Inge |
|
Senescent F-cells - from oncogene amplification to cellular senescence |
| Ambros, Peter F |
|
Unequivocal Identification of Disseminated Tumor Cells in the Bone Marrow by Immunofluorescence and FISH reveal essential Functional and Prognostic Information |
| Ambros, Peter F |
|
Expression profiling of aggressive and benign neuroblastic tumors: is there a common pattern? |
| Angelini, Paola |
|
Ganglioneuroma in childhood: the Italian experience with 127 cases |
| Angelini, Paola |
|
Spinal cord compression (SCC) in neuroblastoma: the Italian experience from 1999-2003 |
| Angelini, Paola |
|
Skeletal involvement in infants with neuroblastoma. A quality control attempt. |
| Aoyama, Mineyoshi |
|
LIM-only protein, LMO3, is up-regulated and acts as an oncogene in aggressive neuroblastomas by physically interacting with a neuronal bHLH transcription factor, HEN2 |
| Armstrong, Jane |
|
Effect of R116010 on Retinoic Acid Metabolism and Action in Neuroblastoma |
| Asgharzadeh, Shahab |
|
Microarray Expression Profiling Improves Definition of High- and Intermediate-Risk Metastatic Neuroblastomas without MYCN Amplification |
| Ash, Shrifa |
|
13 cis- retinoic acid in children with high-risk neuroblastoma: Is more better? |
| Atsuko, Nakagawa |
|
TrkA Expression in Peripheral Neuroblastic Tumors: Prognostic Significance and Biological Relevance |
| Avigad, Smadar |
|
Telomere length - as a prognostic marker in neuroblastoma |
| Azarbayjani, Faranak |
|
Digoxin inhibits neuroblastoma tumor growth in mice |
| Bachmann, Andre |
|
Polyamine Biosynthetic Pathway as a Drug Target for neuroblastoma Therapy |
| Balwierz, Walentyna |
|
Spinal Cord Compression in Neuroblastoma- Experience of Polish Pediatric Solid Tumors Study Group (PPSTSG) |
| Balwierz, Walentyna |
|
Central nervous system (CNS) involvement in children with neuroblastoma (NBL) at the diagnosis and in relapse |
| Baruchel, Sylvain |
|
Ursolic Acid decreases hypoxia-mediated resistant to apoptosis in SK-N-B2 neuroblastoma cell lines by upregulating caspase-3 activity and downregulating VEGF secretion |
| Battistelli, Luca |
|
Serum levels of sRANKL and OPG in patients with neuroblastoma |
| Begent, Joanna |
|
Spinal Neuroblastoma in Stage 2/3 Disease – Experience From One Institution |
| Bell, Emma |
|
The role of MYCN amplification in the p53 response to DNA damage |
| Berthold, Frank |
|
From genotype to phenotype in neuroblastoma: The derivation of clinically different entities |
| Bestagno, Marco |
|
Production of dimeric small immunoproteins specific for neuroblastoma-associated antigen GD2 |
| Betts, David |
|
High-hyperdiploidy, an overlooked sub-group in neuroblastoma |
| Biagiotti, Tiziana |
|
On the search of neuroblastoma stem cell compartment: electrophysiological and immunocytochemical studies |
| Bilke, Sven |
|
Phylogeny of Neuroblastoma Tumor Progression from Comparative Genomic Hybridization Data |
| Blaes, Franz |
|
Immunopathogenesis of Opsoclonus-Myoclonus-Syndrome |
| Boensch, Marc |
|
Quantitative Real-Time PCR for the simultaneous determination of prognostic markers MYCN amplification, deletion 1p and 11q |
| Bogenmann, Emil |
|
Neuroblastoma Differentiation is Regulated by the Cooperation of the RET and TRKA Signaling Pathways |
| Boni, Luca |
|
Influence of age on stage 4 neuroblastoma |
| Borgström, Per |
|
The use of liposomal busulphan in high-dose therapy of neuroblastoma |
| Bosco, Maria Carla |
|
Flavopiridol induces cell cycle arrest and apoptosis in human neuroblastoma cells. Enhancement by hypoxia and correlation with MYCN inhibition |
| Bourdeaut, Franck |
|
Germline mutations of the paired-like homeobox 2B (PHOX2B) gene in hereditary neuroblastoma. |
| Bozzi, Fabio |
|
Bone marrow infiltration in neuroblastoma: a flow cytometric tri-colour assay |
| Brignole, Chiara |
|
Anti-tumour effects of anti-GD2-targeted liposomal antisense oligonucleotides result from a CpG-mediated immune stimulatory effect synergising with an anti-c-myb effect |
| Brodeur, Garrett |
|
Functional and Expression Analysis of CHD5, a Candidate Neuroblastoma Suppressor on 1p36 |
| Bruchelt, Gernot |
|
Pitfalls in detection of contaminating neuroblastoma cells by tyrosine hydroxylase RT-PCR due to catecholamine-producing hematopoietic (stem) cells |
| Burchill, Sue |
|
Quality assurance of reverse transcriptase polymerase chain reaction (RT-PCR) to detect neuroblastoma: ESIOP Neuroblastoma Group |
| Calvet, Loreley |
|
In vivo resistance to CPT-11 in neuroblastoma: Does pleiotrophin play a role? |
| Campostrini, Natascia |
|
Proteomic analysis of an orthotopic neuroblastoma animal model |
| Cañete, Adela |
|
Comparison of two induction regimens for high-risk neuroblastoma |
| Carén, Helena |
|
Methylation studies of genes located in the chromosome region 1p36.2 in neuroblastoma tumors |
| Carr, Jane |
|
Selection for p53 mutant cells by cytotoxic agents in neuroblastoma |
| Castagnola, Elio |
|
Neutropenia and fever in children with neuroblastoma treated with the European High-Risk Protocol. A mono-institutional experience |
| Castellani, Maria Rita |
|
Assessment of chemotherapy response by MIBG scan: a blind quality control |
| Castelli, Chiara |
|
Antigen specific immunity in neuroblastoma patients: antibody and T-cell recognition of NY-ESO-1 tumor antigen |
| Castle, Valerie |
|
p53/MEK1/NF-kappaB Signaling Pathway Mediates Anticancer Drugs Induced Cell Death in N-type Neuroblastoma Cells |
| Castle, Valerie |
|
Chemotherapy Induced S-Type Cell Death Via A Caspase-9 Dependant, p53 Independent Mechanism |
| Castriconi, Roberta |
|
Analysis of susceptibility of Neuroblastoma to NK-mediated killing and identification of a novel cell surface antigen expressed by Neuroblastoma |
| Cecchetto, Giovanni |
|
The importance of Surgical Risk Factors (SRF) in primary surgery for localized neuroblastoma (NBL): results of LNESG I Study |
| Cenacchi, Nicola |
|
Induction of the BH3-only HRK and BBC3 Correlates with Sensitivity to Fenretinide in Neuroblastoma Cell Lines |
| Cesi, Vincenzo |
|
IGFBP-5 in neuroblastoma: complex regulations and multiple effects. |
| Chan, Godfrey CF |
|
Safety and Systemic Availability of Intravenous and Oral Arsenic Trioxide (As2O3) in Children with Relapsed / Refractory Neuroblastoma |
| Chang, Christina L. |
|
Nucleoside diphosphate kinase A/NM23-H1 is a metastasis promoter and not a suppressor in human neuroblastoma |
| Chen, Qingrong |
|
Probabilistic Analysis of cDNA Array-CGH Profiles Identifies Genomic Alterations Specific to Stage and MYCN-Amplification in Neuroblastoma |
| Chen, Yuyan |
|
Expression of the PPM1D gene is associated with poor prognosis in Neuroblastoma |
| Chesler, Louis |
|
Small molecule inhibitors of PI3-Kinase suppress growth of neuroblastoma cell lines by destabilizing Mycn protein |
| Cheung, Belamy |
|
The estrogen-responsive B box protein: a novel co-activator of tumor suppressor gene RARbeta in neuroblastoma |
| Cheung, Irene |
|
Measuring circulating neuroblastoma cells by quantitive RT-PCR: correlation with paired bone marrow and standard disease markers |
| Cheung, Nai-Kong |
|
Early use of anti-GD2 antibody 3F8 plus reduction from 7 to 5 cycles of dose-intensive induction chemotherapy can improve molecular response in high-risk neuroblastoma (NB) |
| Chiesa, Carlo |
|
Dosimetry in 131I-MIBG mieloablative therapy |
| Coco, Simona |
|
LOH analysis on microdissected neuroblastic cells reveals undetected interstitial deletions at chromosome 1p36 in neuroblastoma |
| Cohn, Susan |
|
Inhibition of Angiogenesis by the Epidermal Growth Factor (EGF)-module of the Follistatin Domain of SPARC is Conformation-Dependent |
| Combaret, Valérie |
|
Circulating MYCN DNA as a tumor-specific marker in neuroblastoma patients: Results of a blind multicentric study |
| Combaret, Valérie |
|
Discrimination between good and bad prognosis neuroblastoma by serum protein expression profiles analysis |
| Combaret, Valérie |
|
Genome-wide analysis of gene expression in neuroblastomas detected by mass screening |
| Conte, Massimo |
|
Malignant Neuroblastic Tumors (NTs) in the Adolescent (10-18 y). The Italian Experience with 51 Cases |
| Corrias, Maria Valeria |
|
Low dose interferon-( producing human neuroblastoma cells show reduced proliferation and delayed tumorigenicity |
| Corrias, Maria Valeria |
|
Evaluation of efficacy of NK cell therapy in human neuroblastoma-bearing mice |
| Cosimo, Emilio |
|
Enhancement of targeted radiotherapy in neuroblastoma: a novel gene therapy approach |
| Croce, Michela |
|
Neuroblastoma immunotherapy with IL-12 and IL-15-gene modified NB cells |
| Das, Bikul |
|
Ursolic Acid decreases hypoxia-mediated resistant to apoptosis by upregulating caspase-3 activity and downregulating VEGF secretion in a MYCN amplified neuroblastoma cell line |
| Dau, Daniela |
|
Neuroblastoma in the Adult. A Report on 24 Cases |
| Davidoff, Andrew |
|
Interferon-mediated anti-angiogenic therapy for neuroblastoma |
| De Ambrosis, Alessandro |
|
Constitutive and IFN-inducible expression of the Caspase-8 gene in Neuroblastoma cells is regulated through an essential Interferon-Sensitive Response Element (ISRE) |
| De Bernardi, Bruno |
|
Metastaic/multifocal neuroblastoma in the first year of life |
| De Geer, Anna |
|
Cytotoxic T lymphocytes activated on third party targets induce cell death in neuroblastomas in a MHC-independent fashion |
| De Lagausie, Pascal |
|
Laparoscopic adrenal surgery for neuroblastomas in children |
| De Preter, Katleen |
|
Combined subtractive cDNA cloning and array CGH: an efficient approach for identification of overexpressed genes in DNA amplicons |
| De Preter, Katleen |
|
A putative haplo-insufficient contribution of SDHD to high stage neuroblastoma tumorigenesis |
| De Preter, Katleen |
|
Isolation of normal neuroblastoma precursor cells: tools for comparative gene expression profiling |
| DeClerck, Yves |
|
Bone Marrow Derived Matrix Metalloproteinase-9 Regulates Maturation of Neuroblastoma Vasculature |
| DeClerck, Yves |
|
Bone Marrow Mesenchymal Stem Cells are Essential for Osteoclast Activation in Bone Invasion by Human Neuroblastoma |
| DeClerck, Yves |
|
Combination therapy of zoledronate and low-dose cyclophosphamide improves survival in a xenograft model of bone invasion in neuroblastoma |
| DeClerck, Yves |
|
Absence of plasminogen activator inhibitor-1 inhibits angiogenesis and progression in neuroblastoma |
| Desai, Sunil |
|
A single institution study of low dose 1311mIBG therapy for stage 4 neuroblastoma – therapeutic implications |
| Di Francesco, Angela Maria |
|
The novel 7-substitued camptothecin analog ST1481 (GIMATECAN) is active in preclinical models of human neuroblastoma |
| Djurisic, Marina |
|
Our experience with diagnosis of neuroblastoma using cytogenetic, molecular cytigenetic and molecular techniques |
| Domenicotti, Cinzia |
|
Protein kinase C isoforms and glutathione levels: a molecular switch between proliferation and apoptosis in human neuroblastoma cells |
| Dominici, Carlo |
|
c-KIT expression identifies a subset of aggressive neuroblastomas |
| Dominici, Carlo |
|
Therapeutic activity of STI571 in neuroblastoma xenografts |
| Douc-Rasy, Sétha |
|
The neurogene BTG2 is transactivated by DeltaNp73alpha via p53 in neuroblastoma cell lines |
| Douc-Rasy, Sétha |
|
cDNA macroarrays analyses of p73-target genes reveal that Wnt8A is up-regulated by DeltaN-p73 in SH-SY5Y cells |
| Douc-Rasy, Sétha |
|
Characterization of p53 mutation in neuroblastoma cell lines |
| Drozynska, Elzbieta |
|
Proliferative activity in relationships with established prognostic factors in neuroblastoma |
| Eckschlager, Tomas |
|
Effect of BS RNASE on chemo resistant neuroblastoma cell lines |
| Eggert, Angelika |
|
Application of Proteomics to Identify Novel Targets of Trk-Signaling in Neuroblastoma Cells |
| Ejeskär, Katarina |
|
Introduction of in vitro transcribed ENO1 mRNA into neuroblastoma cells induces massive cell death |
| Ernestus, Karen |
|
Expression of the therapy relevant makers EGF receptor, PDGF receptor and c-Kit in neuroblastoma determined with a multitissue array |
| Fest, Stefan |
|
Anti-neuroblastoma immunotherapy with GD2 Peptide Mimotope DNA Vaccines |
| Fischer, Matthias |
|
Identification of a gene signature discriminating stage 4S and stage 4 neuroblastoma using Serial Analysis of Gene Expression |
| Fix, Ann |
|
Characterization of amplicons in neuroblastoma cell lines and tumours by microarray-based comparative genomic hybridization |
| Flægstad, Trond |
|
Silencing of MYCN expression in human neuroblastoma cell lines |
| Flægstad, Trond |
|
Internalization and mitochondria targeting are involved in the cytotoxic activity against MYCN-amplified neuroblastoma cells by the petide LfcinB |
| Flahaut, Marjorie |
|
Induced doxorubicin resistance in caspase-8/10 silenced neuroblastoma cell lines results in multi-drug resistance that involves early and p53-independent anti-apoptotic mechanisms |
| Flux, Glenn |
|
Whole-body and tumour dosimetry for I-131 mIBG for neuroblastoma |
| Flux, Glenn |
|
Standardised reporting of I-123 mIBG scans for determination of response to induction chemotherapy |
| Fredlund, Erik |
|
Global gene-expression analysis in hypoxic neuroblastoma cells |
| Fulda, Simone |
|
Smac agonists as novel therapeutics to overcome resistance of neuroblastoma cells against radiation therapy |
| Fulda, Simone |
|
Resveratrol, a novel survivin antagonist: sensitization of neuroblastoma cells for TRAIL- or anticancer drug-induced apoptosis through cell cycle-mediated survivin depletion |
| Gallego, Soledad |
|
Tyrosine Hydroxylase expression in blood of patients with Neuroblastoma: Analysis by a real time RT-PCR quantitative assay |
| Gaze, Mark |
|
Intensive Targeted Chemoradiotherapy Of Metastatic Neuroblastoma With High-Dose Iodine-131 Labelled Meta-Iodobenzylguanidine, Topotecan And Haemopoietic Support |
| Geerts, Dirk |
|
MEIS1 functions as a neuroblastoma oncogene |
| Geli, Janos |
|
Frequent transcriptional silencing of RASSF5 (NORE1A) in human pheochromocytomas and neuroblastomas |
| Giannini, Giuseppe |
|
The protoncogene HMGA1 is a molecular target for MYCN in neuroblastoma |
| Goranov, Bojidar |
|
Morphological cell variants in the SH-SY5Y cell populations |
| Gotoh, Takahiro |
|
Prediction of MYCN amplification in neuroblastoma using serum DNA and real-time quantitative PCR |
| Grandinetti, Kathryn |
|
The neuronal-specific RNA-binding protein HuD regulates MYCN expression and gene copy number in neuroblastoma cells |
| Grigoryan, Rita |
|
Cyclophosphamide, but not melphalan or carboplatin, synergistically enhanced topotecan activity against neuroblastoma cell lines in hypoxia |
| Gross, Nicole |
|
Vessel characterisation in an orthotopic model of neruoblastoma |
| Guillaud-Bataille, Marine |
|
Quantitative analysis and detailed mapping of 17q gains in neuroblastomas using array CGH |
| Haber, Michelle |
|
Association Of High-Level MRP1 Expression With Poor Clinical Outcome In A Large Prospective Study Of Primary Neuroblastoma |
| Haber, Michelle |
|
The TH-MYCN Transgenic Mouse As A Preclinical Testing Model For Neuroblastoma |
| Harris, Linda |
|
The Defective G1 Cell Cycle Checkpoint in Neuroblastoma is Mediated by the Inability of p21Waf1/Cip1 to bind to or inhibit Cyclin E-Dependent Cdk2 Kinase Activity |
| Harris, Linda |
|
p53 and JNK Apoptotic Pathways in Neuroblastoma |
| Hayashi, Kunihiko |
|
Effectiveness of mass-screening program on neuroblastoma mortality in 1995-2000 birth cohort of Japan: Nationwide Neuroblastoma Mortality Study |
| Henrich, Kai-Oliver |
|
HsCAMTA1 and FLJ10737 within a commonly deleted region at 1p36 in neuroblastoma |
| Hero, Barbara |
|
Observation of infants with stage 2 or stage 3 single copy MYCN neuroblastoma without chemotherapy |
| Hero, Barbara |
|
Immunosuppression with cyclophosphamide in the treatment of patients with opsomyoclonus syndrome |
| Hiyama, Eiso |
|
Gene expression profiling of neuroblastoma cell lines treated identifies genes upregulated by retinoic acid that are overexpressed in favorable neuroblastoma primary tumors |
| Ho, Ruth |
|
Epidermal Growth Factor Receptor Mediated Survival of Human Neuroblastomas |
| Hoebeeck, Jasmien |
|
Hunting for a 3p tumor suppressor gene in neuroblastoma: a combined genomic and functional approach |
| Hogarty, Michael |
|
Deregulated WNT/BCATENIN pathway in neuroblastoma without MYCN amplification |
| Hogarty, Michael |
|
BH3-domain peptidomimetics activate apoptosis and elucidate death pathways in neuroblastoma |
| Hogarty, Michael |
|
Analysis of MCL1 as a candidate oncogene within the 1Q region of gain in high-risk neuroblastomas |
| Holmquist, Linda |
|
Hypoxia induced dedifferentiation of neuroblastoma cells: phenotypic persistency after reoxygenation |
| Horwacik, Irena |
|
Isolation and Characterisation of Peptide Mimotopes of the Neuroblastoma-associated Carbohydrate Antigen GD2 Ganglioside |
| Huebener, Nicole |
|
Predicted MHC class I Epitopes deriving from Mouse Tyrosine Hydroxylase Are as Effective in DNA Vaccination Against Murine Neuroblastoma as MHC class I Ligands Naturally Expressed on Neuroblastoma Cell Surface |
| Ichikawa, Hitoshi |
|
Gene Expression Associated with Prognosis of Neuroblastoma |
| Iehara, Tomoko |
|